{"id":3980,"date":"2023-07-05T10:58:33","date_gmt":"2023-07-05T10:58:33","guid":{"rendered":"https:\/\/www.sygnaturediscovery.com\/poster\/prism\/"},"modified":"2026-01-22T17:26:41","modified_gmt":"2026-01-22T17:26:41","slug":"prism","status":"publish","type":"poster","link":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/prism\/","title":{"rendered":"Building Diverse Hit-Finding Collections Through Novel Chemistries"},"content":{"rendered":"<h3><span style=\"font-family: georgia, palatino, serif; color: black;\">At Sygnature Discovery, we have a long history of building novel screening compound collections. As the nature of targets that are being progressed for drug discovery have become increasingly complex and challenging, the nature of the compound libraries we use for hit finding against these targets have also seen significant changes, recognising the need for better control of physicochemical properties, three-dimensional character and rigidity.<\/span><\/h3>\n<p><span style=\"font-family: georgia, palatino, serif; color: black;\">During our participation in the European Lead Factory (ELF), our chemists contributed 41k compounds over 5 years (2013-2018), based on 66 novel 3-dimensional scaffolds. Building upon this success, we have since built our own LeadFinder Prism collection (2018-present day), a novel, high fraction sp3 and proprietary screening collection of &gt;60k compounds unique to Sygnature Discovery. In this poster, we highlight some of the chemistry methodology behind a selection of novel and readily accessible structural scaffolds that we have developed through our compound generation pipeline \u2013 each is synthetically tractable and has been used by our High Throughput Chemistry (HTC) team to generate significant numbers of novel, lead-like compounds to enrich hit finding activities.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"featured_media":2637,"template":"","category":[682,718,690,678],"class_list":["post-3980","poster","type-poster","status-publish","has-post-thumbnail","hentry","category-chemistry","category-high-throughput-chemistry","category-hit-identification","category-integrated-drug-discovery"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>LeadFinder Prism: Novel 3D Scaffolds for Hit Finding<\/title>\n<meta name=\"description\" content=\"See the chemistry behind LeadFinder Prism, Sygnature&#039;s proprietary screening collection of more than 60,000 novel high-sp3 compounds. View the poster.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/prism\/\" \/>\n<meta property=\"og:locale\" content=\"fr_CA\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"LeadFinder Prism: Novel 3D Scaffolds for Hit Finding\" \/>\n<meta property=\"og:description\" content=\"See the chemistry behind LeadFinder Prism, Sygnature&#039;s proprietary screening collection of more than 60,000 novel high-sp3 compounds. View the poster.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/prism\/\" \/>\n<meta property=\"og:site_name\" content=\"Sygnature\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-22T17:26:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/DoT_Sept23_PRISM_Portrait-NO-QR-CODE.png\" \/>\n\t<meta property=\"og:image:width\" content=\"724\" \/>\n\t<meta property=\"og:image:height\" content=\"1024\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Estimation du temps de lecture\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/poster\\\/prism\\\/\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/poster\\\/prism\\\/\",\"name\":\"LeadFinder Prism: Novel 3D Scaffolds for Hit Finding\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/poster\\\/prism\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/poster\\\/prism\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/DoT_Sept23_PRISM_Portrait-NO-QR-CODE.png\",\"datePublished\":\"2023-07-05T10:58:33+00:00\",\"dateModified\":\"2026-01-22T17:26:41+00:00\",\"description\":\"See the chemistry behind LeadFinder Prism, Sygnature's proprietary screening collection of more than 60,000 novel high-sp3 compounds. View the poster.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/poster\\\/prism\\\/#breadcrumb\"},\"inLanguage\":\"fr-CA\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/poster\\\/prism\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/poster\\\/prism\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/DoT_Sept23_PRISM_Portrait-NO-QR-CODE.png\",\"contentUrl\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/DoT_Sept23_PRISM_Portrait-NO-QR-CODE.png\",\"width\":11986,\"height\":16946,\"caption\":\"Building Diverse Hit-Finding Collections Through Novel Chemistries\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/poster\\\/prism\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Building Diverse Hit-Finding Collections Through Novel Chemistries\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/\",\"name\":\"Sygnature Discovery\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#organization\"},\"alternateName\":\"Sygnature\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-CA\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#organization\",\"name\":\"Sygnature Discovery\",\"alternateName\":\"Sygnature\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Logo.svg\",\"width\":1,\"height\":1,\"caption\":\"Sygnature Discovery\"},\"image\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.youtube.com\\\/@sygnature.discovery\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/sygnature-discovery\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"LeadFinder Prism: Novel 3D Scaffolds for Hit Finding","description":"See the chemistry behind LeadFinder Prism, Sygnature's proprietary screening collection of more than 60,000 novel high-sp3 compounds. View the poster.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/prism\/","og_locale":"fr_CA","og_type":"article","og_title":"LeadFinder Prism: Novel 3D Scaffolds for Hit Finding","og_description":"See the chemistry behind LeadFinder Prism, Sygnature's proprietary screening collection of more than 60,000 novel high-sp3 compounds. View the poster.","og_url":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/prism\/","og_site_name":"Sygnature","article_modified_time":"2026-01-22T17:26:41+00:00","og_image":[{"url":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/DoT_Sept23_PRISM_Portrait-NO-QR-CODE.png","width":724,"height":1024,"type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Estimation du temps de lecture":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/prism\/","url":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/prism\/","name":"LeadFinder Prism: Novel 3D Scaffolds for Hit Finding","isPartOf":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/prism\/#primaryimage"},"image":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/prism\/#primaryimage"},"thumbnailUrl":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/DoT_Sept23_PRISM_Portrait-NO-QR-CODE.png","datePublished":"2023-07-05T10:58:33+00:00","dateModified":"2026-01-22T17:26:41+00:00","description":"See the chemistry behind LeadFinder Prism, Sygnature's proprietary screening collection of more than 60,000 novel high-sp3 compounds. View the poster.","breadcrumb":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/prism\/#breadcrumb"},"inLanguage":"fr-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.sygnaturediscovery.com\/fr\/poster\/prism\/"]}]},{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/prism\/#primaryimage","url":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/DoT_Sept23_PRISM_Portrait-NO-QR-CODE.png","contentUrl":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/DoT_Sept23_PRISM_Portrait-NO-QR-CODE.png","width":11986,"height":16946,"caption":"Building Diverse Hit-Finding Collections Through Novel Chemistries"},{"@type":"BreadcrumbList","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/prism\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.sygnaturediscovery.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Building Diverse Hit-Finding Collections Through Novel Chemistries"}]},{"@type":"WebSite","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#website","url":"https:\/\/www.sygnaturediscovery.com\/fr\/","name":"Sygnature Discovery","description":"","publisher":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#organization"},"alternateName":"Sygnature","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.sygnaturediscovery.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-CA"},{"@type":"Organization","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#organization","name":"Sygnature Discovery","alternateName":"Sygnature","url":"https:\/\/www.sygnaturediscovery.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Logo.svg","contentUrl":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Logo.svg","width":1,"height":1,"caption":"Sygnature Discovery"},"image":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.youtube.com\/@sygnature.discovery","https:\/\/www.linkedin.com\/company\/sygnature-discovery\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/poster\/3980","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/poster"}],"about":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/types\/poster"}],"version-history":[{"count":0,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/poster\/3980\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/media\/2637"}],"wp:attachment":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/media?parent=3980"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/category?post=3980"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}